Evonik Industries AG: insider trades · Germany · BaFin

About Evonik Industries AG

Evonik Industries AG is a specialty chemicals group listed on Xetra/Frankfurt (DAX/MDAX/SDAX) in Germany and headquartered in Essen. The company in its current form dates back to September 12, 2007, when RAG-Beteiligungs-AG was renamed Evonik Industries AG. Its industrial roots are far older: Theodor Goldschmidt founded Chemische Fabrik Th. Goldschmidt in Berlin in 1847, and the business later moved to Essen, where it helped establish the Goldschmidtstraße site. Today, Evonik is a global specialty chemicals company with operations in more than 100 countries, production plants in 27 countries, and about 31,000 employees.\n\nEvonik’s business model is centered on higher-value niche positions rather than commodity chemicals. The group states that around 80% of sales come from market-leading positions, which supports pricing power, customer stickiness, and resilience across cycles. Since 2025, the company has reorganized its operating business into two core segments, Custom Solutions and Advanced Technologies, with an additional Infrastructure segment. This structure is intended to better separate customer-facing solution businesses from technology- and efficiency-driven platforms. Key business lines include additives for coatings, adhesives and polyurethane foams, catalysts, specialty amines, ingredients for cosmetics and home care, high-performance polymers, crosslinkers, hydrogen peroxide, animal nutrition amino acids, and solutions for health care and biopharma.\n\nFrom a competitive perspective, Evonik stands out for its broad application expertise, strong R&D culture, and international manufacturing footprint. Its strategic growth themes are precision biosolutions, circular economy, and energy transition, reflecting management’s intent to create additional sales over the medium term from innovation-led platforms. The company’s product portfolio is embedded in end markets such as automotive, construction, plastics, energy, coatings, and life sciences, where performance, formulation know-how, and regulatory compliance are critical.\n\nRecent developments reinforce this positioning. In 2025, Evonik advanced sustainability initiatives by switching selected production lines to renewable electricity, opening a large alkoxides plant in Singapore, and announcing partnerships focused on thermoplastic automation and recycling. In February 2026, the company confirmed that it had met its 2025 guidance and introduced a new dividend policy. For investors, Evonik combines the characteristics of a defensive specialty chemicals platform with global reach, a significant innovation engine, and value-creation potential linked to portfolio simplification and operational efficiency.